[Drug therapy in cardiogenic shock].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008616:Mephentermine / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000503:physiopathology
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D004071:Digitalis Glycosides; D010643:Phenoxybenzamine; D005934:Glucagon; D007545:Isoproterenol; D008616:Mephentermine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
Pharmakotherapie des kardiogenen Schocks.